MedCap’s Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

MedCap’s wholly owned subsidiary, Unimedic Pharma AB, has today completed the previously announced acquisition of 100% of the shares in XGX Pharma ApS (“XGX”) in Denmark.

The acquisition was announced on June 25, 2025, and has now received the necessary regulatory approval (Foreign Direct Investment) in Denmark.

The information was submitted for publication, through the agency of the contact person, on 21-07-2025 12:00 CEST.